Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Info |  Desc |  Pointed To By FileMan Files |  Pointer To FileMan Files |  Fields |  Found Entries  | All
Print Page as PDF
Global: ^PS(51.28

Package: Pharmacy Data Management

Global: ^PS(51.28


Information

FileMan FileNo FileMan Filename Package
51.28 PHARMACOGENOMIC PHENOTYPES Pharmacy Data Management

Description

Pointed To By FileMan Files, Total: 2

Package Total FileMan Files
Pharmacy Data Management 2 PHARMACOGENOMIC GENES(#51.26)[#51.263(.01)]    PHARMACOGENOMIC PHENOTYPES(#51.28)[99.97]    

Pointer To FileMan Files, Total: 1

Package Total FileMan Files
Pharmacy Data Management 1 PHARMACOGENOMIC PHENOTYPES(#51.28)[99.97]    

Fields, Total: 7

Field # Name Loc Type Details
.01 NAME 0;1 FREE TEXT
************************REQUIRED FIELD************************

  • INPUT TRANSFORM:  K:$L(X)>75!($L(X)<1)!'(X'?1P.E) X
    MAXIMUM LENGTH: 75
  • LAST EDITED:  APR 23, 2025
  • HELP-PROMPT:  Enter the name of the Phenotype. The answer must be 1-75 characters in length.
  • DESCRIPTION:  
    This is the name of the Phenotype. This field, in addition to the synonyms also in this file, will enable the software to derive a vendor phenotype to be used in the pharmacogenomic order check for medication orders.
  • PRE-LOOKUP:  I $G(DIC(0))["L",'$D(XUMF) K X D EN^DDIOL("Entries must be edited via the Master File Server (MFS).","","!?5")
  • DELETE TEST:  1,0)= D:'$D(XUMF) EN^DDIOL("Entries must be inactivated via the Master File Server(MFS).","","!?5") I '$D(XUMF)
  • LAYGO TEST:  1,0)= D:'$D(XUMF) EN^DDIOL("Entries must be added via the Master File Server(MFS).","","!?5") I $D(XUMF)
    WRITE AUTHORITY: ^
  • FIELD INDEX:  B (#1771) REGULAR IR LOOKUP & SORTING
    Short Descr: This cross reference sets the global PS(51.28,"B",X,DA)="".
    Description: This is the "B" cross reference on the NAME (#01) Field. This cross reference, along with the Synonym and Name cross references, will be used when converting a Phenotype from a lab test to a First DataBank Phenotype,
    enabling successful pharmacogenomic order checking.
    Set Logic: S ^PS(51.28,"B",$E(X,1,75),DA)=""
    Kill Logic: K ^PS(51.28,"B",$E(X,1,75),DA)
    Whole Kill: K ^PS(51.28,"B")
    X(1): NAME (51.28,.01) (Subscr 1) (Len 75) (forwards)
1 FIRST DATABANK PHENOTYPE 0;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>75!($L(X)<1) X
    MAXIMUM LENGTH: 75
  • LAST EDITED:  APR 23, 2025
  • HELP-PROMPT:  Enter the name of the First Databank Phenotype. The answer must be 1-75 characters in length.
  • DESCRIPTION:  
    This field provides the mapping from the lab test Phenotype to the First DataBank Phenotype. The First DataBank Phenotype will be used when processing the pharmacogenomic order checks provided by First DataBank.
  • FIELD INDEX:  C (#1772) REGULAR IR LOOKUP & SORTING
    Short Descr: This cross reference sets the global PS(51.28,"C",X,DA)="".
    Description: This is the "C" cross reference on the FIRST DATABANK PHENOTYPE (#1) Field. This cross reference, along with the SYNONYM and NAME cross references, will be used when converting a Phenotype from a lab test to a
    corresponding First DataBank Phenotype, enabling successful pharmacogenomic order checking.
    Set Logic: S ^PS(51.28,"C",$E(X,1,75),DA)=""
    Kill Logic: K ^PS(51.28,"C",$E(X,1,75),DA)
    Whole Kill: K ^PS(51.28,"C")
    X(1): FIRST DATABANK PHENOTYPE (51.28,1) (Subscr 1) (Len 75) (forwards)
2 SYNONYM 1;0 Multiple #51.282 51.282

  • DESCRIPTION:  
    This multiple contains a list of synonyms for the NAME field, which is the name of the Phenotype.
99.97 REPLACED BY VHA STANDARD TERM VUID;3 POINTER TO PHARMACOGENOMIC PHENOTYPES FILE (#51.28) PHARMACOGENOMIC PHENOTYPES(#51.28)

  • LAST EDITED:  APR 22, 2025
  • HELP-PROMPT:  Enter the VHA standard term that replaces this term.
  • DESCRIPTION:  This field is populated when one Term/Concept replaces another Term/Concept. This field is controlled by standardization and should only be changed by standardization processes. This field contains a pointer to a VHA
    standard term that replaces this entry.
  • CROSS-REFERENCE:  51.28^AREPLACETERM
    1)= S ^PS(51.28,"AREPLACETERM",$E(X,1,30),DA)=""
    2)= K ^PS(51.28,"AREPLACETERM",$E(X,1,30),DA)
    This cross-reference can be used to identify the replacement entries associated with a Term/Concept.
99.98 MASTER ENTRY FOR VUID VUID;2 SET
************************REQUIRED FIELD************************
  • '0' FOR NO;
  • '1' FOR YES;

  • LAST EDITED:  APR 22, 2025
  • HELP-PROMPT:  Enter '1' for 'Yes' if this entry is the Master entry for this VUID.
  • DESCRIPTION:  
    This field identifies the Master entry for a VUID associated with a Term/Concept.
  • RECORD INDEXES:  AMASTERVUID (#1770)
99.99 VUID VUID;1 FREE TEXT

  • INPUT TRANSFORM:  S X=+X K:$L(X)>20!($L(X)<1)!'(X?1.20N) X
    MAXIMUM LENGTH: 20
  • LAST EDITED:  APR 23, 2025
  • HELP-PROMPT:  : Enter the VHA Unique ID (VUID) that represents this VHA wide term.
  • DESCRIPTION:  
    This number represents the VHA Unique ID (VUID). It is a unique meaningless integer assigned to reference terms VHA wide.
  • NOTES:  XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER
  • CROSS-REFERENCE:  51.28^AVUID
    1)= S ^PS(51.28,"AVUID",$E(X,1,30),DA)=""
    2)= K ^PS(51.28,"AVUID",$E(X,1,30),DA)
    This cross-reference is by VUID.
  • RECORD INDEXES:  AMASTERVUID (#1770)
99.991 EFFECTIVE DATE/TIME TERMSTATUS;0 DATE Multiple #51.2899 51.2899

  • DESCRIPTION:  
    This multiple field contains the history of changes to the status of this reference term, along with the date/time of each change.

Found Entries, Total: 51

NAME: DECREASED FUNCTION    NAME: DEFICIENT    NAME: DECREASED OR NORMAL FUNCTION    NAME: DECREASED RISK FOR ADVERSE EVENT    NAME: FAVORABLE GENOTYPE RESPONSE    NAME: HIGH RISK    NAME: HIGH/NORMAL ENZYME ACTIVITY    NAME: INCREASED CHANCE FOR TREATMENT EFFICACY    
NAME: INCREASED FUNCTION    NAME: INCREASED RISK FOR ADVERSE EVENT    NAME: INCREASED RISK FOR THERAPEUTIC FAILURE    NAME: INDETERMINANT ACTIVITY    NAME: INTERMEDIATE ACETYLIZER    NAME: INTERMEDIATE ENZYME ACTIVITY    NAME: INTERMEDIATE METABOLIZER    NAME: LIKELY INTERMEDIATE METABOLIZER    
NAME: LIKELY POOR METABOLIZER    NAME: LOW ENZYME ACTIVITY    NAME: LOW RISK    NAME: LOW SENSITIVITY    NAME: MALIGNANT HYPERTHERMIA SUSCEPTIBILITY    NAME: NORMAL FUNCTION    NAME: NORMAL ACTIVITY    NAME: NORMAL METABOLIZER    
NAME: NORMAL RESPONSE    NAME: NORMAL TO VARIABLE METABOLIZER    NAME: OTHER ABNORMAL    NAME: POOR FUNCTION    NAME: POOR METABOLIZER    NAME: POSSIBLE INTERMEDIATE METABOLIZER    NAME: RAPID ACETYLIZER    NAME: RAPID METABOLIZER    
NAME: REDUCED ACTIVITY    NAME: REDUCED RESPONSE    NAME: SLOW ACETYLIZER    NAME: SLOW METABOLIZER    NAME: ULTRARAPID METABOLIZER    NAME: UNCERTAIN SUSCEPTIBILITY    NAME: UNCERTIAN SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA    NAME: UNFAVORABLE GENOTYPE RESPONSE    
NAME: VARIABLE FUNCTION    NAME: VARIANT ALLELE ABSENT    NAME: NORMAL RISK OF AMINOGLYCOSIDE-INDUCED HEARING LOSS    NAME: VARIANT ALLELE PRESENT    NAME: INCREASED RISK OF AMINOGLYCOSIDE-INDUCED HEARING LOSS    NAME: NO PHENOTYPE    NAME: UNCERTAIN RISK OF AMINOGLYCOSIDE-INDUCED HEARING LOSS    NAME: SEE LAB PANEL COMMENT    
NAME: SCANNED    NAME: SEE COMMENT IN PDF    NAME: SEE REPORT    
Info |  Desc |  Pointed To By FileMan Files |  Pointer To FileMan Files |  Fields |  Found Entries  | All